EVIDENCE LIBRARY
ICU Bronchoscopy Trial Found Less Hypotension but Similar Median Recovery With Remimazolam
A 120-adult trial found fewer hypotensive events and sedation rescues with remimazolam. The reported median recovery time was the same in both groups, qualifying stronger wording elsewhere in the paper.
A 120-adult trial found fewer hypotensive events and sedation rescues with remimazolam. The reported median recovery time was the same in both groups, qualifying stronger wording elsewhere in the paper.
The measured comparison
He and colleagues randomized critically ill bronchoscopy patients with liver or kidney dysfunction to remimazolam or propofol. Both groups completed bronchoscopy, with median times of five minutes to the target sedation depth.
Hypotension occurred in 3.33% versus 20%, and sedation rescues in 3.33% versus 16.67%, favoring remimazolam. Median return to pretest consciousness was seven minutes in both groups, without a significant difference.
Separate the tables from broader conclusions
The paper’s closing discussion describes shorter recovery, but the reported median comparison did not demonstrate that advantage. Likewise, no significant difference in liver or kidney indexes does not establish that the drug is entirely unaffected by all forms of organ dysfunction.
The single-center sample and short procedural observation limit generalization and rare-event assessment. The study did not establish every long-term clinical or cognitive outcome.
A careful summary
Use the favorable pressure and rescue findings without adding an unsupported recovery benefit. The results concern selected patients undergoing a specific procedure. They cannot prove that remimazolam would prevent an individual patient’s hypotension or guarantee recovery at seven minutes.
Source paper
Original analysis of the supplied journal article, identified as PMC12542442.